Murray Medical Limited Filleted accounts for Companies House (small and micro)

Murray Medical Limited Filleted accounts for Companies House (small and micro)


0 false false false false false false false false false true false false false false false false No description of principal activity 2019-04-01 Sage Accounts Production Advanced 2020 - FRS102_2019 xbrli:pure xbrli:shares iso4217:GBP 07357989 2019-04-01 2020-03-31 07357989 2020-03-31 07357989 2019-03-31 07357989 2019-03-31 07357989 core:PlantMachinery 2019-04-01 2020-03-31 07357989 core:FurnitureFittings 2019-04-01 2020-03-31 07357989 bus:Director1 2019-04-01 2020-03-31 07357989 core:PlantMachinery 2019-03-31 07357989 core:FurnitureFittings 2019-03-31 07357989 core:LandBuildings 2020-03-31 07357989 core:PlantMachinery 2020-03-31 07357989 core:FurnitureFittings 2020-03-31 07357989 core:WithinOneYear 2020-03-31 07357989 core:WithinOneYear 2019-03-31 07357989 core:ShareCapital 2020-03-31 07357989 core:ShareCapital 2019-03-31 07357989 core:RetainedEarningsAccumulatedLosses 2020-03-31 07357989 core:RetainedEarningsAccumulatedLosses 2019-03-31 07357989 core:LandBuildings 2019-03-31 07357989 core:PlantMachinery 2019-03-31 07357989 core:FurnitureFittings 2019-03-31 07357989 bus:SmallEntities 2019-04-01 2020-03-31 07357989 bus:AuditExemptWithAccountantsReport 2019-04-01 2020-03-31 07357989 bus:FullAccounts 2019-04-01 2020-03-31 07357989 bus:SmallCompaniesRegimeForAccounts 2019-04-01 2020-03-31 07357989 bus:PrivateLimitedCompanyLtd 2019-04-01 2020-03-31
COMPANY REGISTRATION NUMBER: 07357989
Murray Medical Limited
Filleted Unaudited Financial Statements
31 March 2020
Murray Medical Limited
Statement of Financial Position
31 March 2020
2020
2019
Note
£
£
£
Fixed assets
Tangible assets
4
9,592
10,989
Current assets
Stocks
9,650
9,820
Debtors
5
6,000
8,761
Cash at bank and in hand
5,000
1,765
--------
--------
20,650
20,346
Creditors: amounts falling due within one year
6
30,134
24,509
--------
--------
Net current liabilities
9,484
4,163
-------
--------
Total assets less current liabilities
108
6,826
----
-------
Net assets
108
6,826
----
-------
Capital and reserves
Called up share capital
100
100
Profit and loss account
8
6,726
----
-------
Shareholder funds
108
6,826
----
-------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 March 2020 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 16 February 2021 , and are signed on behalf of the board by:
Mr D Murray
Director
Company registration number: 07357989
Murray Medical Limited
Notes to the Financial Statements
Year ended 31 March 2020
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 753 Beechley Drive, Fairwater, Cardiff, CF5 3SJ.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Plant & equip
-
25% reducing balance
Fixtures & Fittings
-
25% reducing balance
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities. Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability. Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.
4. Tangible assets
Land and buildings
Plant and machinery
Fixtures and fittings
Total
£
£
£
£
Cost
At 1 April 2019 and 31 March 2020
5,400
12,658
4,197
22,255
-------
--------
-------
--------
Depreciation
At 1 April 2019
8,594
2,672
11,266
Charge for the year
1,016
381
1,397
-------
--------
-------
--------
At 31 March 2020
9,610
3,053
12,663
-------
--------
-------
--------
Carrying amount
At 31 March 2020
5,400
3,048
1,144
9,592
-------
--------
-------
--------
At 31 March 2019
5,400
4,064
1,525
10,989
-------
--------
-------
--------
5. Debtors
2020
2019
£
£
Trade debtors
8,761
Other debtors
6,000
-------
-------
6,000
8,761
-------
-------
6. Creditors: amounts falling due within one year
2020
2019
£
£
Bank loans and overdrafts
20,736
Trade creditors
4,622
Corporation tax
2,501
1,082
Social security and other taxes
4,466
3,766
Other creditors
2,431
15,039
--------
--------
30,134
24,509
--------
--------
7. Related party transactions
The company was under the control of MrD Murray throughout the current year. Mr Murray is the managing director and majority shareholder.